This educational course covers SAMHSAs Medication for Opioid Use Disorders TIP publication. The following will be addressed in the readings: the review of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This education covers the Treatment planning skill of the Eight Counselor Skill Groups ascribed by NAADAC and NCC AP.
Upon completion of this education course, the participant will be able to:
- Explain the role of medications for the treatment of opioid use disorder;
- Assess the role of treatment counselors with clients and healthcare professionals;
- Identify resources related to medications for opioid use disorder;
- Describe pharmacotherapy for opioid use disorder.
Substance Abuse and Mental Health Services Administration. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63. Publication No. PEP20-02-01-006. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2020.
Exam written by: Tamika Lett, PhD Human Services, NCAC II, CSAC, CCTP, QMHP A/C
